http://www.zibb.com/all/theme/cq/Ondine+Biopharma+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 17 Nov 2009 13:59:35 GMTTue, 17 Nov 2009 13:59:35 GMT608831http://www.zibb.com/all/theme/cq/Ondine+Biopharma+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5675770/Ondine+Biopharma+to+acquire+Advanced+Photodynamic+TechnologiesOndine Biopharma Corporation has signed a definitive agreement to acquire 100% stake in Advanced Photodynamic Technologies, Inc. (APT), a US-based developer of photodynamic drugs and devices for antimicrobial and oncotherapeutic applications, in an all share transaction. Ondine Biopharma is ahttp://www.zibb.com/article/5675770/Ondine+Biopharma+to+acquire+Advanced+Photodynamic+TechnologiesOndine Biopharma CorporationTue, 17 Nov 2009 13:59:35 GMThttp://www.biospace.com/news_story.aspx?StoryID=153195&full=1VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 13, 2009) - Ondine Biopharma Corporation (the "Company" or "Ondine" (TSX: OBP)(AIM: OBP) a medical device company developing photodisinfection based products, today announced its financial results for the secondhttp://www.biospace.com/news_story.aspx?StoryID=153195&full=1Ondine Biopharma CorporationThu, 13 Aug 2009 12:00:00 GMThttp://www.newratings.com/main/company_headline.m?section=company&option=headline&id=1719697NEW YORK, March 27 (newratings.com) - Analysts at Canaccord Adams maintain their "buy" rating on Ondine Biopharma Corp (ticker: OBG). The target price has been reduced from C$2.42 to C$1.90. [<ahttp://www.newratings.com/main/company_headline.m?section=company&option=headline&id=1719697Ondine Biopharma CorporationThu, 27 Mar 2008 09:28:54 GMThttp://www.zibb.com/article/5664460/Ondine+Biopharma+Announces+Third+Quarter+Financial+ResultsOndine Biopharma Corporation (the "Company" or "Ondine") (TSX: OBP)(AIM: OBP) a medical device company developing photodisinfection based products, today announced its financial results for the third quarter ended September 30, 2009. "During the third quarter of 2009, wehttp://www.zibb.com/article/5664460/Ondine+Biopharma+Announces+Third+Quarter+Financial+ResultsOndine Biopharma CorporationThu, 12 Nov 2009 09:31:05 GMThttp://www.zibb.com/article/5543833/Ondine+Biopharma+Raises+from+Partial+Sale+of+Grafton+InvestmentOndine Biopharma Corporation (the "Company" or "Ondine") (TSX: OBP)(AIM: OBP), a medical device company developing photodisinfection based products, today announced it has received cash proceeds of $618,000 (US$577,500) from the sale of 21,000 Ordinary Shares of Grafton Resourcehttp://www.zibb.com/article/5543833/Ondine+Biopharma+Raises+from+Partial+Sale+of+Grafton+InvestmentOndine Biopharma CorporationWed, 23 Sep 2009 08:40:36 GMThttp://www.zibb.com/article/5543831/Ondine+Biopharma+Raises+from+Partial+Sale+of+Grafton+InvestmentOndine Biopharma Corporation (the "Company" or "Ondine") (TSX:OBP)(AIM:OBP), a medical device company developing photodisinfection based products, today announced it has received cash proceeds of $618,000 (US$577,500) from the sale of 21,000 Ordinary Shares of Grafton Resourcehttp://www.zibb.com/article/5543831/Ondine+Biopharma+Raises+from+Partial+Sale+of+Grafton+InvestmentOndine Biopharma CorporationWed, 23 Sep 2009 08:39:43 GMT